Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LINE Lineage

交易中 05-02 10:12:16 EDT

46.47

-0.75

-1.59%

最高48.45	最低46.19	成交量15.52万
今开47.36	昨收47.22	日振幅4.79%
总市值106.22亿	流通市值32.81亿	总股本2.29亿
成交额726.55万	换手率0.22%	流通股本7,061万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LINE","market":"US","secType":"STK","nameCN":"Lineage","latestPrice":46.4675,"timestamp":1746195133873,"preClose":47.22,"halted":0,"volume":155156,"delay":0,"floatShares":70606429,"shares":228590171,"eps":-3.209638,"marketStatus":"交易中","change":-0.7525,"latestTime":"05-02 10:12:16 EDT","open":47.361,"high":48.45,"low":46.19,"amount":7265517.94008,"amplitude":0.047861,"askPrice":46.54,"askSize":125,"bidPrice":46.29,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-3.209638,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746216000000},"marketStatusCode":2,"adr":0,"listingDate":1721880000000,"exchange":"NASDAQ","adjPreClose":47.22,"dividendRate":0.030882,"preHourTrading":{"tag":"盘前","latestPrice":47.21,"preClose":47.22,"latestTime":"09:27 EDT","volume":940,"amount":44416.48802,"timestamp":1746192427907},"postHourTrading":{"tag":"盘后","latestPrice":47.21,"preClose":47.22,"latestTime":"19:58 EDT","volume":422,"amount":19949.5298,"timestamp":1746143882437},"volumeRatio":0.892163,"impliedVol":0.3991,"impliedVolPercentile":0.7917},"requestUrl":"/m/hq/s/LINE/wiki","defaultTab":"wiki","newsList":[{"id":"2532008091","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速跳水5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532008091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532008091?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:32","pubTimestamp":1746106343,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时32分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅跳水5.81%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。其相关个股中，Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cyclacel Pharmaceuticals, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、Onconetix, Inc.较为活跃，换手率分别为28.83%、14.83%、11.60%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.、Metagenomi, Inc.，振幅分别为14.25%、12.22%、11.56%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213223a46ef228&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213223a46ef228&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4007","LCTX","BK4224","BK4139","LENZ"],"gpt_icon":0},{"id":"2532072722","title":"Baird：维持Lineage(LINE.US)评级，由优于大市调整至优于大市评级, 目标价由70.00美元调整至64.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532072722","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532072722?lang=zh_cn&edition=full","pubTime":"2025-05-01 20:59","pubTimestamp":1746104387,"startTime":"0","endTime":"0","summary":"Baird：维持Lineage(LINE.US)评级，由优于大市调整至优于大市评级, 目标价由70.00美元调整至64.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/01205950082921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LINE"],"gpt_icon":0},{"id":"2532099817","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近收盘股价大涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532099817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532099817?lang=zh_cn&edition=full","pubTime":"2025-05-01 04:16","pubTimestamp":1746044162,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日04时16分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅拉升5.94%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.77%。其相关个股中，Regulus Therapeutics Inc.、Nutriband Inc C/Wts 、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Purple Biotech Ltd、Processa Pharmaceuticals, Inc.、Regulus Therapeutics Inc.较为活跃，换手率分别为167.34%、129.45%、43.01%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Nutriband Inc C/Wts 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为64.00%、62.63%、42.50%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501041602aa2c8036&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501041602aa2c8036&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4007","LINE","LENZ","BK4139","BK4224"],"gpt_icon":0},{"id":"1128270468","title":"异动解读 | Lineage股价盘中大跌5.59%，Q1营收不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1128270468","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128270468?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:33","pubTimestamp":1746020024,"startTime":"0","endTime":"0","summary":"周三盘中，Lineage股价大幅下跌5.59%，主要受到公司发布的2025年第一季度财报影响。尽管每股收益超出预期，但营收数据未能达到分析师的预测，引发了投资者的担忧。根据Lineage公布的财报显示，公司2025年第一季度实现营收12.92亿美元，低于市场预期的13.4亿美元，同时也低于上一季度的13.28亿美元。市场将继续关注Lineage未来的业务发展策略，以及公司如何应对当前的增长挑战。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Lineage股价盘中大跌5.59%，Q1营收不及预期","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LINE"],"gpt_icon":0},{"id":"2531105997","title":"Lineage, Inc.盘中异动 股价大跌5.59%报53.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531105997","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531105997?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:31","pubTimestamp":1746019883,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时31分，Lineage, Inc.股票出现异动，股价急速跳水5.59%。截至发稿，该股报53.33美元/股，成交量2943股，换手率0.00%，振幅0.62%。Lineage, Inc.股票所在的房地产信托行业中，整体跌幅为0.53%。其相关个股中，Office Properties Income Trust、Mackenzie Realty Capital, Inc.、Industrial Logistics Properties Trust涨幅较大，Wheeler Real Estate Investment Trust, Inc.、Creative Media、Cherry Hill Mortgage Investment Corporation较为活跃，换手率分别为1.25%、0.40%、0.22%，振幅较大的相关个股有Mackenzie Realty Capital, Inc.、凯特地产信托、Hudson Pacific Properties, Inc.，振幅分别为5.22%、3.64%、3.40%。Lineage, Inc.公司简介：Lineage Inc是一家房地产投资信托。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213123a6cee7b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213123a6cee7b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2531032674","title":"Norwegian Cruise Line：2025年Q1财报实现营收21.27亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2531032674","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531032674?lang=zh_cn&edition=full","pubTime":"2025-04-30 20:11","pubTimestamp":1746015089,"startTime":"0","endTime":"0","summary":"Norwegian Cruise Line(NCLH.US)：2025年Q1财报实现营收21.27亿美元，前值为21.91亿美元，预期值为21.5亿美元；每股收益为0.07美元，前值为0.16美元，预期值为0.09美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430204108a6cedd80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430204108a6cedd80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","NCLH"],"gpt_icon":0},{"id":"2531081759","title":"Lineage(LINE.US)：2025年Q1财报实现营收12.92亿美元，前值为13.28亿美元，预期值为13.4亿美元；每股收益为0.01美元，前值为-0.28美元，预期值为-0.06美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531081759","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531081759?lang=zh_cn&edition=full","pubTime":"2025-04-30 18:11","pubTimestamp":1746007866,"startTime":"0","endTime":"0","summary":"Lineage(LINE.US)：2025年Q1财报实现营收12.92亿美元，前值为13.28亿美元，预期值为13.4亿美元；每股收益为0.01美元，前值为-0.28美元，预期值为-0.06美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30181150050194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LINE"],"gpt_icon":0},{"id":"2531777862","title":"Kaia宣布获得风投机构投资，Blockchain Capital和1kx领投","url":"https://stock-news.laohu8.com/highlight/detail?id=2531777862","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531777862?lang=zh_cn&edition=full","pubTime":"2025-04-30 14:45","pubTimestamp":1745995535,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/kaiachain/status/1917383581326008575?s=46","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["LINE","KAIA.USD.HKCC","EVM","SPAQ.U","BK4224"],"gpt_icon":0},{"id":"2531923499","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531923499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531923499?lang=zh_cn&edition=full","pubTime":"2025-04-28 23:16","pubTimestamp":1745853396,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日23时16分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速下挫5.08%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Cg Oncology, Inc.、Portage Biotech Inc.、Ibio, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Springworks Therapeutics, Inc.较为活跃，换手率分别为2380.81%、454.38%、80.91%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Ibio, Inc.，振幅分别为50.32%、36.31%、25.02%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428231636a46aaac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428231636a46aaac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4224","LINE","LCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2530813135","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌6.10%报0.468美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530813135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530813135?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:38","pubTimestamp":1745588316,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时38分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速下挫6.10%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Azitra Inc、Geovax Labs, Inc.、60 Degrees Pharmaceuticals, Inc.涨幅较大，Azitra Inc、Briacell Therapeutics Corp.、Acrivon Therapeutics, Inc.较为活跃，换手率分别为207.37%、57.65%、42.72%，振幅较大的相关个股有Acrivon Therapeutics, Inc.、Azitra Inc、Cardio Diagnostics Holdings Inc.，振幅分别为16.76%、16.34%、13.41%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213836a466e4ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213836a466e4ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4007","LINE","LENZ","BK4139","BK4224"],"gpt_icon":0},{"id":"2530690689","title":"Lineage Cell Therapeutics, Inc.盘中异动 下午盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530690689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530690689?lang=zh_cn&edition=full","pubTime":"2025-04-25 02:25","pubTimestamp":1745519115,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日02时25分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅拉升5.19%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425022515a6c6f9d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425022515a6c6f9d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LCTX","BK4224","BK4007","LINE","LENZ"],"gpt_icon":0},{"id":"2529653538","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.56%报0.454美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529653538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529653538?lang=zh_cn&edition=full","pubTime":"2025-04-24 00:56","pubTimestamp":1745427397,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日00时56分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速拉升5.56%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Ensysce Biosciences, Inc.、Silexion Therapeutics Corp涨幅较大，Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Plus Therapeutics, Inc.较为活跃，换手率分别为6105.69%、717.64%、124.25%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Ensysce Biosciences, Inc.、Silexion Therapeutics Corp，振幅分别为223.08%、85.03%、75.55%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042400563894dfd897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042400563894dfd897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","LINE","BK4224","LCTX"],"gpt_icon":0},{"id":"2529682014","title":"Lineage, Inc.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529682014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529682014?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:48","pubTimestamp":1745416110,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时48分，Lineage, Inc.股票出现异动，股价大幅拉升5.01%。Lineage, Inc.股票所在的房地产信托行业中，整体涨幅为1.56%。Lineage, Inc.公司简介：Lineage Inc是一家房地产投资信托。消息层面，截至21时48分，《巴克莱：维持Norwegian Cruise Line评级，由增持调整至增持评级, 目标价由32.00美元调整至23.00美元。》资讯为影响Lineage, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423214831aa2c78c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423214831aa2c78c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2529655384","title":"巴克莱：维持Norwegian Cruise Line评级，由增持调整至增持评级, 目标价由32.00美元调整至23.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529655384","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529655384?lang=zh_cn&edition=full","pubTime":"2025-04-23 02:09","pubTimestamp":1745345351,"startTime":"0","endTime":"0","summary":"巴克莱：维持Norwegian Cruise Line(NCLH.US)评级，由增持调整至增持评级, 目标价由32.00美元调整至23.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042302122994de7155&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042302122994de7155&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","NCLH"],"gpt_icon":0},{"id":"2529531900","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅上涨5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529531900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529531900?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:50","pubTimestamp":1745337053,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时50分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速上涨5.82%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.66%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222350539740dc00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222350539740dc00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","LINE","BK4224","LCTX"],"gpt_icon":0},{"id":"2528743993","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘急速上涨5.33%报0.439美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528743993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528743993?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:30","pubTimestamp":1744896605,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时30分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅拉升5.33%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Lineage Cell Therapeutics, Inc.、Quince Therapeutics, Inc.、Compugen医疗涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为324.13%、122.75%、41.43%，振幅较大的相关个股有Cel-Sci Corporation、Novabay Pharmaceuticals, Inc.、Protalix Biotherapeutics, Inc. ，振幅分别为2.87%、0.53%、0.38%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213006a6be097f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213006a6be097f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","BK4007","LENZ","BK4224","LINE"],"gpt_icon":0},{"id":"2527421443","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527421443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527421443?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:12","pubTimestamp":1744726322,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时12分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速上涨5.18%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Mural Oncology Plc、Skye Bioscience, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为750.28%、226.10%、88.99%，振幅较大的相关个股有Skye Bioscience, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc，振幅分别为171.53%、80.08%、66.02%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415221202aa2c6ff2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415221202aa2c6ff2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","LCTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2527192989","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近午盘股价大跌5.17%报0.446美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527192989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527192989?lang=zh_cn&edition=full","pubTime":"2025-04-14 23:32","pubTimestamp":1744644754,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日23时32分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速下跌5.17%。截至发稿，该股报0.446美元/股，成交量30.611万股，换手率0.13%，振幅3.96%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.08%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041423323494d51f2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041423323494d51f2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224","LCTX","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2526061066","title":"Lineage Cell Therapeutics, Inc.盘中异动 下午盘大幅拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526061066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526061066?lang=zh_cn&edition=full","pubTime":"2025-04-12 03:11","pubTimestamp":1744398707,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日03时11分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.05%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.98%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2144.32%、1796.03%、405.65%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为193.75%、156.27%、77.44%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041203114794d32bd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041203114794d32bd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","BK4224","LCTX","BK4007","BK4139"],"gpt_icon":0},{"id":"1166565406","title":"Lineage Cell Therapeutics 2024年第四季度GAAP每股收益$(0.02) 超过预期$(0.03)，销售额$2.900百万 超预期$1.621百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1166565406","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166565406?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:08","pubTimestamp":1741637306,"startTime":"0","endTime":"0","summary":"公司报告季度销售额$2.900百万，超过了分析师共识预估的$1.621百万，提高了78.88%。与去年同期的销售额$2.100百万相比，这一数字增长了38.10%。以上内容来自Benzinga Earnings专栏，原文如下：$Lineage$ Cell $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 33.33 percent. This is a 33.33 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $2.900 million which beat the analyst consensus estimate of $1.621 million by 78.88 percent.  This is a 38.10 percent","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE","LCTX","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onelineage.com","stockEarnings":[{"period":"1week","weight":-0.1625},{"period":"1month","weight":-0.1703},{"period":"3month","weight":-0.213},{"period":"6month","weight":-0.3466},{"period":"1year","weight":-0.3946},{"period":"ytd","weight":-0.1938}],"compareEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":-0.0045},{"period":"3month","weight":-0.072},{"period":"6month","weight":-0.022},{"period":"1year","weight":0.1162},{"period":"ytd","weight":-0.0471}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage, Inc.于2017年在马里兰州成立，是世界上最大的全球温度控制仓库房地产投资信托基金，拥有现代化和战略性的房地产网络。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.009942},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.051794},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.047075},{"month":4,"riseRate":0.909091,"avgChangeRate":0.072457},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.085175},{"month":6,"riseRate":0.7,"avgChangeRate":0.017118},{"month":7,"riseRate":0.6,"avgChangeRate":-0.034691},{"month":8,"riseRate":0.2,"avgChangeRate":-0.040778},{"month":9,"riseRate":0.4,"avgChangeRate":-0.041279},{"month":10,"riseRate":0.7,"avgChangeRate":0.025106},{"month":11,"riseRate":0.4,"avgChangeRate":-0.07115},{"month":12,"riseRate":0.6,"avgChangeRate":-0.044918}],"exchange":"NASDAQ","name":"Lineage","nameEN":"Lineage"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lineage,LINE,Lineage股票,Lineage股票老虎,Lineage股票老虎国际,Lineage行情,Lineage股票行情,Lineage股价,Lineage股市,Lineage股票价格,Lineage股票交易,Lineage股票购买,Lineage股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}